NCT00293800View on ClinicalTrials.gov

A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

173

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions
Open-Angle GlaucomaOcular Hypertension
Interventions
DRUG

Travoprost 0.004%/Timolol 0.5% Ophthalmic Solution

Investigational ophthalmic solution intended for the treatment of open-angle glaucoma or ocular hypertension

DRUG

Latanoprost 0.005% Ophthalmic Solution (XALATAN)

Commercially marketed ophthalmic solution for the treatment of open-angle glaucoma or ocular hypertension

DRUG

Timolol 0.5% Ophthalmic Solution

Ophthalmic solution for the treatment of open-angle glaucoma or ocular hypertension

OTHER

Timolol Vehicle

Placebo

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY